Dermadream operates in the skincare and pharmaceutical industries, focusing on aesthetic product distribution and skincare devices. The company is the exclusive distributor of AestheFill, a dermal filler, in Brazil and actively participates in industry events, such as the Congress of the Brazilian Society of Botulinum Toxin and Facial Aesthetics. In addition to distribution, Dermadream markets its own line of skincare devices under the My Derma Dream brand. This includes the FDA-cleared MicroSculpt microcurrent device, designed to enhance circulation and muscle tone, as well as red light therapy devices aimed at anti-aging. The company targets Brazilian aesthetic professionals and consumers, promoting its products with a 90-day money-back guarantee. Dermadream's dual focus on B2B and B2C markets positions it uniquely within the industry.
我們正在追蹤 Dermadream 的市場擴張
Dermadream 的國際擴張與競爭對手的比較
Dermadream你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Dermadream你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
Hugel與巴西Derma Dream合作，瞄準拉丁美洲肉毒素市場。在里約熱內盧和聖保羅舉行'Letybo'預發布活動。
Hugel為60名巴西皮膚科醫生舉辦了為期3天的研討會，以加深對Letybo品牌的理解，包括診所參觀、工廠參觀和交流會議。
PharmaResearch與DermaDream簽署Rejuran在巴西的獨家供應協議，標誌著進軍拉丁美洲美容市場的戰略性舉措。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Dermadream 業務、市場及增長訊號的快速解答。
